Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2024-05-22 19:22
To improve the understanding and prevention and control capabilities of chronic diseases among the grassroots population and help solve the difficulties faced by ordinary people in accessing medical care and medication, a "Healthy Yuan, Lizhu Pharmaceutical Chronic Disease Public Welfare Support for Rural Revitalization" and Jiangshan City Chronic Disease Free Clinic and Drug Delivery event was held in the Xunli Village hall in the 28th Du Town of Jiangshan City on the morning of May 22. Zhou Junwang, president of the Jiangshan City Charity Federation, Zhou Shunfu, director of the Municipal Health and Health Bureau, and other relevant leaders, as well as volunteers from the Taohuayuan Foundation, Healthy Yuan, and Lizhu Pharmaceutical attended the event. At the launch ceremony, Healthy Yuan and Lizhu Pharmaceutical donated cardiovascular, hypertension, hyperlipidemia, and gastric disease medications worth 1 million yuan to the Jiangshan City area, planning to fully launch the "2024 Healthy Yuan, Lizhu Pharmaceutical Chronic Disease Public Welfare Support for Rural Revitalization" campaign in urban and rural areas of the city. In addition, a free clinic was also held on-site, attracting local chronic disease patients and village representatives. It is understood that the donated chronic disease medications will be distributed in batches according to local conditions to help chronic disease patients in difficult families and reduce their medical burden. The first batch of medications was distributed at this event.
Time Posted：2024-05-22 19:00
On May 22, the "Chronic Disease Public Welfare Project to Support Rural Revitalization," jointly promoted by Health Yuan and Lizhu Group, arrived in Toktok County, Inner Mongolia Autonomous Region, where a donation ceremony was held at the County Party and Government Conference Center. Zhang Xiaodong, member of the Standing Committee of the County Committee and Deputy County Head; Nasen Ulitu, Deputy Director of the Government Office; leaders from the County Health and Health Commission and the County Red Cross Society; and volunteers from Health Yuan and Lizhu Group attended the event. Toktok County is located in the central part of Inner Mongolia Autonomous Region, on the Tumot Plain at the northern bank of the boundary between the upper and middle reaches of the Yellow River and the southern foot of Daqing Mountain. In recent years, the county has vigorously implemented the "Rural Talents Supporting Rural Revitalization" action, calling on rural talents in the medical field to take root at the grassroots level, popularize health knowledge, and effectively solve problems in disease prevention, diagnosis, treatment, and post-illness difficulties. 2024 is a year for deepening the effective connection between consolidating the achievements of poverty alleviation and rural revitalization. The economic burden caused by disease is one of the most prominent factors and a key area needing improvement in supporting rural revitalization. Establishing a long-term chronic disease prevention and control system is an important part of rural revitalization work. With the development of the economy and society, especially the aging population and changes in residents' production and lifestyles, the incidence of chronic diseases in China has generally shown an upward trend and is becoming younger. Data from the seventh national census in China shows that in 2023, there were approximately 180 million chronic disease patients in China. Among them, low-income patients in remote areas face significant challenges in medical security, including the accessibility and affordability of medicines. Chronic disease prevention and control work in Toktok County is one of the important directions for the county's health undertakings and rural revitalization work. The 1 million yuan worth of chronic disease treatment drugs donated by Health Yuan and Lizhu Group will effectively support the county's comprehensive chronic disease prevention and control construction, reduce the economic burden on local patients, and prevent low-income families from falling into or returning to poverty due to illness. This year marks the seventh year of the Health Yuan and Lizhu Group chronic disease public welfare project. Since the end of 2018, Health Yuan, relying on its pharmaceutical company advantages, has donated chronic disease medicines to remote areas across the country many times, effectively helping to improve the level of basic medical services.
Time Posted：2024-05-08 17:16
Recently, the Red Cross Society of China issued a notice on awarding medals and plaques to donors who have made outstanding contributions to the Chinese Red Cross cause in 2023. LiZhu Pharmaceutical Group Co., Ltd. and its parent company, Joincare Pharmaceutical Group Industry Co., Ltd., were awarded the "Special Contribution Award" and the "China Red Cross Charity Medal", respectively.
Time Posted：2024-04-26 16:43
On the evening of April 25, 2024, Health Yuan (600380.SH), a leading manufacturer of respiratory drugs, disclosed its first-quarter performance. From January to March 2024, the company achieved operating revenue of 4.34 billion yuan and net profit attributable to shareholders of 440 million yuan. Sales of the company's key specialized respiratory products made a significant contribution to overall revenue, reaching 417 million yuan in the first quarter, accounting for 9.61% of total revenue.
Q1 Business Development Transaction Overview
Time Posted：2024-04-24 14:29
The first quarter of 2024 has passed quickly. This review summarizes the major business development (BD) transactions in the pharmaceutical field from January to March, providing insights into the current market situation and trends. Based on publicly available information from sources such as Meibai Capital and various listed company announcements, a total of 50 transactions were completed in the Chinese pharmaceutical sector this quarter. This includes 12 license-in transactions, 27 license-out transactions, and 11 domestic transactions. Compared to the 32 transactions in the first quarter of 2022, this represents a 56% increase. It has also been observed that 32 of these 50 transactions originated from information released at the J.P. Morgan Healthcare Conference in the United States at the beginning of 2024.
Time Posted：2024-04-18 15:30
On the evening of April 17, Healthy Yuan announced that the Phase III multicenter clinical trial of its innovative drug product TG-1000 capsules had met its primary endpoint. The company will soon communicate with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) regarding the marketing application for this drug to treat influenza, and will promote the drug's listing process.
Time Posted：2024-03-26 12:00
On March 20, a "Public Welfare Chronic Disease Prevention and Treatment Project" jointly launched by Healthy Yuan, Lizhu Group, and the Tibet Qizheng Charity Foundation arrived in Bomê County, Linzhi City, Tibet Autonomous Region. A drug donation ceremony was held in front of the county committee building in Zammu. Zhoma Yangjin, the deputy county magistrate; Niu Haiyan, director of the county health and health commission; relevant personnel from the county people's hospital and various township health centers; volunteers from the Tibet Qizheng Charity Foundation; and volunteers from Healthy Yuan and Lizhu Group attended the event.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.